Zevra Therapeutics Inc. Earnings

The next earnings date for Zevra Therapeutics Inc. is August 19, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Zevra Therapeutics Inc. Earnings

Report DateEstimated Earnings Per Share
11/05/2025$-0.07
08/19/2025$2.19

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Zevra Therapeutics Inc. Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/05/2025After Market$-0.0666.92%
03/26/2025After Market$-0.69-73.11%
11/12/2024After Market$-0.69-64.29%
08/13/2024After Market$-0.48-11.63%
05/08/2024Before Market$-0.4016.67%
03/05/2024After Market$-0.40-48.15%
11/07/2023Before Market$-0.40-33.33%
08/14/2023Before Market$-0.1555.88%
05/15/2023After Market$-0.34-47.83%
03/07/2023Before Market$-0.26-52.94%
11/09/2022After Market$-0.19-46.15%
08/11/2022After Market$-0.19-58.33%
05/12/2022After Market$-0.050.00%
03/30/2022After Market$-0.08-14.29%
11/10/2021After Market$-0.0528.57%
08/12/2021After Market$0.21-8.70%
05/13/2021After Market$-0.54-217.65%
03/11/2021After Market$-1.07-67.19%
10/29/2020After Market$-0.6420.00%
08/12/2020After Market$0.16900.00%
05/12/2020After Market$-1.76-1,200.00%
02/28/2020Before Market$-0.1688.24%
11/14/2019After Market$0.96132.11%
08/13/2019After Market$-5.2822.35%
05/14/2019After Market$-7.360.00%
02/28/2019After Market$-3.2062.09%
11/08/2018After Market$-15.04-22.08%
08/09/2018After Market$-14.565.58%
05/10/2018After Market$-28.32-153.76%
03/29/2018After Market$-11.52-5.11%
11/09/2017After Market$-10.88-1.12%
08/10/2017After Market$-7.0430.16%
05/10/2017After Market$-13.44-33.33%
03/09/2017After Market$-10.882.42%
11/09/2016After Market$-14.72-46.76%
08/10/2016Before Market$-9.2822.67%
05/12/2016After Market$-3.2059.18%
03/10/2016After Market$-10.24-27.21%
11/12/2015After Market$-10.88-61.90%
08/13/2015After Market$-39.20-487.71%
05/27/2015After Market$-40-435.48%

More About Zevra Therapeutics Inc.

Website
https://zevra.com
Country
USA
Full Time Employees
59

Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 2 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 1/2 clinical trial to treat narcolepsy. The company is also developing Celiprolol, a prodrug product candidate that is under Phase 3 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit and hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and MIPLYFFA for the treatment of niemann pick disease type C, an ultra-rare neurodegenerative lysosomal storage disorder. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. Zevra Therapeutics, Inc. was incorporated in 2006 and is headquartered in Celebration, Florida.

“Zevra Therapeutics Inc. Earnings” Can Refer to the Zevra Therapeutics Inc. Earnings Date

Some people say “Zevra Therapeutics Inc. earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Zevra Therapeutics Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Zevra Therapeutics Inc. Stock on the Earnings Date

If you own Zevra Therapeutics Inc. stock (ZVRA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Zevra Therapeutics Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Zevra Therapeutics Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Zevra Therapeutics Inc. Earnings

You can contact us any time if you would like to ask questions about Zevra Therapeutics Inc. earnings or anything else related to the stock market.